Jardiance still killing the competition!

Discussion in 'Boehringer Ingelheim' started by anonymous, Sep 12, 2020 at 10:50 PM.

Tags: Add Tags
  1. #1 anonymous, Sep 12, 2020 at 10:50 PM
    anonymous

    anonymous Guest

    Seeing very little movement in Farxiga with their new indications. Jardiance continues to grow and EMPEROR news solidifying position with payors. As good or better in all areas including CKD AND with the best coverage. AZ not moving the needle with customers.
     
    Quote

  2. #2 anonymous, Sep 13, 2020 at 10:56 AM
    anonymous

    anonymous Guest

    this dog and pony just started.
     
    Quote
Reply to Thread